Invention Grant
- Patent Title: Histone demethylase inhibitors
-
Application No.: US15354044Application Date: 2016-11-17
-
Publication No.: US09963441B2Publication Date: 2018-05-08
- Inventor: Toufike Kanouni , Zhe Nie , Jeffrey Alan Stafford , James Marvin Veal
- Applicant: CELGENE QUANTICEL RESEARCH, INC.
- Applicant Address: US CA San Diego
- Assignee: Celgene Quanticel Research, Inc.
- Current Assignee: Celgene Quanticel Research, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wiley Rein, LLP
- Main IPC: C07D401/00
- IPC: C07D401/00 ; C07D401/04 ; C07D401/14 ; A61K31/4439 ; A61K31/444 ; A61K31/4545 ; A61K31/4709 ; A61K31/5377 ; C07D405/14 ; C07D413/14 ; A61K31/00

Abstract:
The present invention relates generally to compositions and methods for treating cancer and neoplastic diseases. Provided herein are substituted imidazole-pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase enzymes. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
Public/Granted literature
- US20170066739A1 HISTONE DEMETHYLASE INHIBITORS Public/Granted day:2017-03-09
Information query